Results 1 to 10 of about 49,551,276 (233)

Rapidly spreading Enterobacterales with OXA-48-like carbapenemases [PDF]

open access: yesJournal of Clinical Microbiology
Enterobacterales (mostly Klebsiella pneumoniae, Escherichia coli) with OXA-48-like carbapenemases (e.g., OXA-48, -181, -232, -244) are undermining the global efficiency of carbapenem therapy. In the Middle East, North Africa, and some European countries,
Gisele Peirano, Johann D. D. Pitout
doaj   +4 more sources

Discovery of bla(OXA-199), a chromosome-based bla(OXA-48)-like variant, in Shewanella xiamenensis. [PDF]

open access: yesPLoS ONE, 2012
INTRODUCTION: bla(OXA-48) is a globally emerging carbapenemase-encoding gene. The progenitor of bla(OXA-48) appears to be a Shewanella species. The presence of the bla(OXA-48)-like gene was investigated for two Shewanella xiamenensis strains.
Zhiyong Zong
doaj   +2 more sources

Emergence of OXA-48-like Carbapenemase-Producing Escherichia coli in Baranya County, Hungary [PDF]

open access: yesAntibiotics
Background: Carbapenem-resistant Escherichia coli (CREC) producing OXA-48-like carbapenemase was first detected in Hungary in 2022. The aim of the present study was to characterize such strains isolated in 2022–2025 in Baranya County, Hungary.
Fatma A. Mohamed   +15 more
doaj   +2 more sources

Improved hydrolysis of piperacillin by OXA-48-like R214G variants, a selective advantage under piperacillin-tazobactam exposure [PDF]

open access: yesAntimicrobial Agents and Chemotherapy
OXA-48-like carbapenemases have rapidly disseminated worldwide, becoming the most common carbapenemase in many countries, with more than 60 variants reported.
Réva Nermont   +5 more
doaj   +2 more sources

Genetic characteristics of OXA-48-producing Enterobacterales from China

open access: yesJournal of Global Antimicrobial Resistance, 2021
: Objectives: In China, OXA-48-producing Enterobacterales have been identified sporadically, causing small-scale regional outbreaks. This study investigated the molecular epidemiology, transmission and evolution of OXA-48-producing Enterobacterales and ...
Lifeng Wang   +3 more
doaj   +3 more sources

One-Step Differential Detection of OXA-48-Like Variants Using High-Resolution Melting (HRM) Analysis [PDF]

open access: yesAntibiotics, 2020
OXA-48-like carbapenemase gene remains a hidden threat, as different OXA-48 variants have varying presentations of susceptibility to antibiotics that might affect the treatment decisions.
Min Yi Lau   +6 more
doaj   +2 more sources

Clinical outcomes of carbapenem therapy in OXA-48–producing Enterobacterales infections: a French multicentre cohort, systematic review, and meta-analysis [PDF]

open access: yesEmerging Microbes and Infections
OXA-48–producing Enterobacterales (OXA-48-PE) represent a growing global health threat. Most of OXA-48–PE remain categorized susceptible to carbapenems, which might encourage their use despite uncertain clinical efficacy.
Laurent Dortet   +8 more
doaj   +2 more sources

Spread of the blaOXA-48/IncL Plasmid within and between Dogs in City Parks, France

open access: yesMicrobiology Spectrum, 2022
The blaOXA-48/IncL plasmid is increasingly reported in dogs, even in the absence of carbapenem use in animals. In this study, we witnessed the spread of this plasmid within and between dogs sharing the same relaxing area.
Marisa Haenni   +4 more
doaj   +1 more source

Characterization of OXA-48-producing Klebsiella oxytoca isolates from a hospital outbreak in Tunisia

open access: yesJournal of Global Antimicrobial Resistance, 2021
Objective: There is very limited information about OXA-48-producing Klebsiella oxytoca. The aim of this study was to describe the phenotypic and molecular characterization of OXA-48-producing K.
Julia Guzmán-Puche   +7 more
doaj   +1 more source

Laboratory detection and clinical implication of oxacillinase-48 like carbapenemase: The hidden threat

open access: yesJournal of Global Infectious Diseases, 2016
Carbapenemase producing Gram-negative pathogen is of great concern for physician. The challenging aspects are treatment option and infection control.
Yamuna Devi Bakthavatchalam   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy